The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback